HUTCHMED (LON:HCM) Stock Price Crosses Below 200-Day Moving Average of $267.29

HUTCHMED (China) Limited (LON:HCM) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 267.29 ($3.33) and traded as low as GBX 267 ($3.32). HUTCHMED shares last traded at GBX 268 ($3.34), with a volume of 66,901 shares trading hands.

HUTCHMED Price Performance

The firm has a 50 day simple moving average of GBX 252.95 and a 200-day simple moving average of GBX 267.29. The company has a quick ratio of 2.97, a current ratio of 2.72 and a debt-to-equity ratio of 11.59. The company has a market cap of £2.26 billion, a PE ratio of 2,680.00 and a beta of 0.68.

HUTCHMED Company Profile

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.